17 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 6 Not applicable, 6 Phase 1, 3 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 5, Terminated 1 |
| Phase 1 | 6 | Completed 5, Terminated 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 4 | 1 | Suspended 1 |
Follow Adult Disease: new trials by email Literature Review of Adult Disease trials Research Report on Adult Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors TT125-802 - Advanced Solid Tumor, Adult Solid Tumor | Phase 1 | Completed | TOLREMO therapeutics AG | 45 | 2023-11-07 | 2026-07-07 |
| Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer HPVDC injection level dose 1, placebo injection level dose 1, HPVDC injection level dose 2 - Head and Neck Carcinoma, Adult Disease | Phase 1 / Phase 2 | Completed | Gustave Roussy, Cancer Campus, Grand Paris | 24 | 2023-07-31 | 2026-09-18 |
| A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) ANV419, Lenalidomide with low-dose dexamethasone, Daratumumab - Multiple Myeloma, Relapsed Cancer | Phase 1 | Terminated | Anaveon AG | 4 | 2023-02-10 | 2024-02-12 |
| A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). ANV419 - Melanoma (Skin), Cutaneous Melanoma | Phase 1 / Phase 2 | Completed | Anaveon AG | 29 | 2022-12-16 | 2025-08-26 |
| Effectiveness of Bio-Healthy Park on Adult Bio-healthy Park - Adult Disease | Not applicable | Completed | Universidad Católica San Antonio de Murcia | 120 | 2022-06-01 | 2024-05-08 |
| Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC Diagnostic Test: CBC-DIFF Monocyte Volume Width Distribution (MDW) - Sepsis, Adult Disease | Completed | Beckman Coulter, Inc. | 198 | 2021-09-05 | 2022-07-18 | |
| Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital CBC-DIFF Monocyte Volume Width Distribution (MDW) - Sepsis, Adult Disease | Completed | Beckman Coulter, Inc. | 127 | 2021-06-17 | 2022-07-18 | |
| A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer. ANV419, Ipilimumab - Advanced Solid Tumor, Adult Disease | Phase 1 | Completed | Anaveon AG | 55 | 2021-05-25 | 2024-11-08 |
| Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients Socket without Revofit system, Socket with Revofit system - Amputation, Adult Disease | Not applicable | Terminated | University Hospital, Angers | 1 | 2021-02-22 | 2022-07-06 |
| New Ways of Doing Magnetic Resonance Imaging in Children and Adults MRI - Pediatric Disorder, Adult Disease | Active not recruiting | Memorial Sloan Kettering Cancer Center | 21 | 2020-11-18 | 2026-09-03 | |
| Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University CBC-DIFF Monocyte Volume Width Distribution (MDW) - Sepsis, Adult Disease | Completed | Beckman Coulter, Inc. | 1139 | 2020-02-03 | 2021-03-17 | |
| Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W CBC-DIFF Monocyte Volume Width Distribution (MDW) - Sepsis, Adult Disease | Completed | Beckman Coulter, Inc. | 1700 | 2019-11-20 | 2021-01-28 | |
| Relationship of the Physical Activity Practice and Its Different Domains With Cardiac Autonomic Modulation Adult Disease | Completed | Bruna Thamyres Ciccotti Saraiva | 252 | 2018-11-10 | 2025-03-26 | |
| Human Phenotype Project Study Protocol Adult Disease | Recruiting | Weizmann Institute of Science | 30000 | 2018-10-01 | 2024-07-16 | |
| The Effect and Safety of the Four Points Transversus Abdominis Plane Block TAP, PVB, Ropivacaine - Liver Diseases, Adult Disease | Not applicable | Completed | Gia Dinh People Hospital | 30 | 2018-08-15 | 2021-01-12 |
| Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients Dexmedetomidine, Placebo (normal saline) - Adult Disease, Intensive Care Unit Syndrome | Phase 4 | Suspended | Peking University First Hospital | 260 | 2017-08-20 | 2025-07-31 |
| HMGB1 Release From Hemorrhagic Shock Patients Intensive Care Unit, Hemorrhagic Shock | Completed | Xingui Dai | 18 | 2017-05-17 | 2018-05-24 | |
| Applying a Stress Framework to Health Behavior Change: A Fitbit Study Fitbit One - Adult Disease | Not applicable | Completed | Brandeis University | 104 | 2015-05-08 | 2017-04-19 |
| The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). Acupuncture, Orientation group - Neoplasm, Adult Disease | Not applicable | Completed | University of Sao Paulo | 32 | 2014-09-01 | 2015-11-13 |
| Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior Home-based exercise, Education, Exercise plus Education - Multiple Sclerosis, Adult Disease | Phase 1 / Phase 2 | Completed | University of Illinois at Urbana-Champaign | 37 | 2013-04-01 | 2014-11-25 |
Showing 20 of 23. Sign in to see all of them.
Disease (23) · Neoplasms (5) · Emergencies (4) · Sepsis (4) · Motor Activity (2) · Recurrence (2) · Delirium (1) · Hematologic Diseases (1) · Liver Diseases (1) · Lung Neoplasms (1) · Melanoma (1) · Multiple Chronic Conditions (1) · Multiple Myeloma (1) · Multiple Sclerosis (1) · Neoplasm Metastasis (1)
Pathologic Processes (23) · Pathological Conditions, Signs and Symptoms (23) · Disease Attributes (7) · Infections (4) · Inflammation (4) · Systemic Inflammatory Response Syndrome (4) · Behavior (2) · Immune System Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1)
Acupuncture Therapy (1) · Dexamethasone (1) · Dexmedetomidine (1) · Educational Status (1) · Exercise (1) · Ipilimumab (1) · Lenalidomide (1) · Lidocaine (1) · Ropivacaine (1) · Saline Solution (1) · Sufentanil (1) · daratumumab (1)
Beckman Coulter, Inc. (4) · Anaveon AG (3) · Prince of Songkla University (2) · Brandeis University (1) · Bruna Thamyres Ciccotti Saraiva (1) · Gia Dinh People Hospital (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Memorial Sloan Kettering Cancer Center (1) · Peking University First Hospital (1) · TOLREMO therapeutics AG (1) · Universidad Católica San Antonio de Murcia (1) · University Hospital, Angers (1) · University of Illinois at Urbana-Champaign (1) · University of Sao Paulo (1) · Washington State University (1)
United States (9) · Spain (5) · France (4) · Switzerland (3) · Brazil (2) · China (2) · Germany (2) · Thailand (2) · Denmark (1) · Israel (1) · Italy (1) · United Kingdom (1) · Vietnam (1)
Eduard Gasal, MD (3) · Amin A Mohammad, Ph. D (1) · Binh V Huynh, Mr (1) · Diego GD Christofaro, PhD (1) · Dong-Xin Wang, MD, PhD (1) · Gerald Behr, MD (1) · Jacob Sosnoff (1) · Joseph Parrillo, MD (1) · Joshua Neumiller, PharmD (1) · Keri Bicking, PharmD (1) · Magdalena Czader, MD (1) · Noelia Gonzalez-Galvez, PhD (1) · Pablo Jorge Marcos-Pardo, PhD (1)
PMID 24751831, PMID 24940804, PMID 25275593, PMID 25540170, PMID 26522327, PMID 31256014, PMID 31593091, PMID 33483920, PMID 36002204, PMID 37030666, PMID 38243906, PMID 39501340
P30AG048785 (1)